Akron Biotechnology, LLC
Bioinspired cryoprotectant agents (CPA cocktails) for low-toxicity cryopreservation of tissues and organs
- Sector
- Biotech
- Total capital
- $2M
- Federal grants
- $822K
- 2 awards · 2015–2017
- Rank in peer group#54 of 502
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- $1.2M
- 5 awards · Defense, Commerce, Health and Human S
- Rank in Biotech#175 of 4373
- Granted patents
- 1
- 12 pending · first 2020
- Rank in peer group#57 of 502
Capital timeline
Latest events
- Federal grantDefense · Phase II · Complex tissue cryopreservation with novel naturally-inspired cryoprotectants$722K
- Federal contractDefense · Igf::ot::igf Armysbir Phase II Proposal A2-6546$720K
- Federal contractHealth and Human S · Igf::ot::igf Reagents$57K
- Federal grantDefense · Phase I · Cryopreservation for Regenerative Medical Applications$100K
- Federal contractDefense · Army Phase I Proposal A151-059-1166 Igf::ot::igf$150K
- Federal contractCommerce · Homogenized Bulk$257K
- Federal contractDefense · Item# AK8217-2508,$15K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 502 peers
Line = medianBiotech · Molecule
- Federal grants#54 · top 11%
- Granted patents#57 · top 11%
- Linked publications#10 · top 2%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 1 granted of 13- GrantedCryosolutions and uses thereofUSPTOUS 10,765,111
- PendingDetection Of Mycoplasma In Cell Cultures And Cell Culture Derived BiologicalsUSPTOApplication 16680460
- PendingCryopreservative Compositions And Methods Of Use ThereofUSPTOApplication 15776636
Show all 13 patent records
- Cryosolutions and uses thereofSep 8, 2020 · US 10,765,111Granted
- Detection Of Mycoplasma In Cell Cultures And Cell Culture Derived BiologicalsAug 20, 2020 · Application 16680460Pending
- Cryopreservative Compositions And Methods Of Use ThereofNov 15, 2018 · Application 15776636Pending
- Cryopreservation And Cell Culture MediaApplication 62828867Pending
- Preservation And Cryopreservation MediaApplication PCTUS2019017488Pending
- Method To Prepare Therapeutically Active Aldesleukin Highly Stable In Liquid Pharmaceutical CompositionsApplication 62684288Pending
- Cryopreservation And Cell Culture MediaApplication PCTUS2020026598Pending
- Preservation And Cryopreservation MediaApplication 62637030Pending
- Methods For Producing Novel And Powerful Regulatory B Cells And Uses ThereofApplication 62635017Pending
- Cryopreservation MediaApplication 62628387Pending
- Cryopreservative Compositions And Methods Of Use ThereofApplication PCTUS2016062064Pending
- Cryopreservative Compositions And Methods Of Use ThereofApplication 62255813Pending
- Method To Prepare Therapeutically Active Aldesleukin Highly Stable In Liquid Pharmaceutical CompositionsApplication PCTUS2019037012Pending
Recent research by its founders
- Charting the translational pathway: ISSCR best practices for the development of PSC-derived therapies20261 cites
- Novel Highly Homeostatic B Cells induced by Immunomodulatory Oligonucleotide IMT50420251 cites
- Engineered Test Tissues: A Model for Quantifying the Effects of Cryopreservation Parameters20233 cites
Related companies, and why
- INSILICOM LLCSimilar federal contract value in Biotech · $1.3M in contracts
- EVESTRA, INC.Similar federal contract value in Biotech · $1.2M in contracts
- APPLIED STEMCELL, INC.Similar federal contract value in Biotech · $1.2M in contracts
- Ultima Genomics, Inc.Similar federal contract value in Biotech · $1.2M in contracts
- VIRTICI LLCSimilar federal contract value in Biotech · $1.2M in contracts
- Htg Molecular Diagnostics, IncSimilar federal contract value in Biotech · $1.2M in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .